Trial Profile
To compare outcomes in patients with Acute Myeloid Leukemia received Fludarabine-Busulfan with the addition of Thiotepa and Fludarabine and Busulfan based myeloablative regimen for allogeneic stem cell transplantation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Jul 2017
Price :
$35
*
At a glance
- Drugs Fludarabine (Primary) ; Busulfan
- Indications Acute myeloid leukaemia
- Focus Adverse reactions; Therapeutic Use
- 20 Jul 2017 New trial record
- 25 Jun 2017 Results presented at the 22nd Congress of the European Haematology Association